MetLife Inc. (NYSE: MET) has a higher price-to-earnings ratio of 22.69x compared to its average ratio, and the 36-month beta value for MET is at 1.09. Analysts have varying views on the stock, with 13 analysts rating it as a “buy,” 2 rating it as “overweight,” 5 as “hold,” and 0 as “sell.”
The average price suggested by analysts for MET is $82.25, which is $25.95 above the current market price. The public float for MET is 659.31M, and currently, shorts hold a 1.21% of that float. The average trading volume for MET on March 17, 2023 was 4.40M shares.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
MET) stock’s latest price update
MetLife Inc. (NYSE: MET)’s stock price has increased by 2.47 compared to its previous closing price of 56.30. Despite this, the company has seen a loss of -10.79% in its stock price over the last five trading days. Barron’s reported on 11/06/22 that MetLife Stock Is Up 20% This Year—and Could Gain More
MET’s Market Performance
MET’s stock has fallen by -10.79% in the past week, with a monthly drop of -19.93% and a quarterly drop of -21.22%. The volatility ratio for the week is 4.36% while the volatility levels for the last 30 days are 2.79% for MetLife Inc. The simple moving average for the last 20 days is -15.42% for MET stock, with a simple moving average of -15.08% for the last 200 days.
Analysts’ Opinion of MET
Many brokerage firms have already submitted their reports for MET stocks, with Goldman repeating the rating for MET by listing it as a “Neutral.” The predicted price for MET in the upcoming period, according to Goldman is $78 based on the research report published on January 09th of the current year 2023.
Jefferies, on the other hand, stated in their research note that they expect to see MET reach a price target of $82, previously predicting the price at $86. The rating they have provided for MET stocks is “Hold” according to the report published on December 09th, 2022.
MET Trading at -17.79% from the 50-Day Moving Average
After a stumble in the market that brought MET to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -25.43% of loss for the given period.
Volatility was left at 2.79%, however, over the last 30 days, the volatility rate increased by 4.36%, as shares sank -20.36% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -20.04% lower at present.
During the last 5 trading sessions, MET fell by -10.79%, which changed the moving average for the period of 200-days by -14.81% in comparison to the 20-day moving average, which settled at $67.47. In addition, MetLife Inc. saw -20.28% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at MET starting from PAPPAS BILL, who sale 2,857 shares at the price of $70.96 back on Mar 02. After this action, PAPPAS BILL now owns 48,915 shares of MetLife Inc., valued at $202,733 using the latest closing price.
PAPPAS BILL, the EVP, Global Tech. & Ops. of MetLife Inc., sale 11,345 shares at $71.96 during a trade that took place back on Feb 27, which means that PAPPAS BILL is holding 46,231 shares at $816,386 based on the most recent closing price.
Stock Fundamentals for MET
Current profitability levels for the company are sitting at:
- +5.43 for the present operating margin
The net margin for MetLife Inc. stands at +3.63. Equity return is now at value 6.60, with 0.30 for asset returns.
In conclusion, MetLife Inc. (MET) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.